Cargando…
MicroRNA Expression Profile Changes in the Leukocytes of Parkinson’s Disease Patients
Parkinson’s disease (PD) is one of the most common movement disorders. It is primarily diagnosed clinically. A correct diagnosis of PD in its early stages is important for the development of a pathogenic treatment, which necessitates a search for potential biomarkers of the disease. We evaluated the...
Autores principales: | Ardashirova, N. S., Abramycheva, N. Yu., Fedotova, E. Yu., Illarioshkin, S. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611861/ https://www.ncbi.nlm.nih.gov/pubmed/36348717 http://dx.doi.org/10.32607/actanaturae.11729 |
Ejemplares similares
-
The SNCA-Rep1 Polymorphic Locus: Association with the Risk of Parkinson’s Disease and SNCA Gene Methylation
por: Iakovenko, E. V., et al.
Publicado: (2020) -
SNCA Gene Methylation in Parkinson’s Disease and Multiple System Atrophy
por: Fedotova, Ekaterina Yu., et al.
Publicado: (2023) -
Whole-Exome Sequencing in Searching for New Variants Associated With the Development of Parkinson’s Disease
por: Shulskaya, Marina V., et al.
Publicado: (2018) -
microRNA Profiles in Parkinson's Disease Prefrontal Cortex
por: Hoss, Andrew G., et al.
Publicado: (2016) -
In vivo profile of the human leukocyte microRNA response to endotoxemia
por: Schmidt, Wolfgang M, et al.
Publicado: (2008)